electroCore, Inc. Proceeds from Sale of Notes Receivable
electroCore, Inc. (ECOR) reported Proceeds from Sale of Notes Receivable of $25.70 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfNotesReceivable · last filed 2022-03-10
- electroCore, Inc. proceeds from sale of notes receivable for the quarter ending 2021-12-31 was $0.00.
- electroCore, Inc. proceeds from sale of notes receivable for the quarter ending 2021-09-30 was $18.80M.
- electroCore, Inc. proceeds from sale of notes receivable for fiscal 2021 was $25.70M.
| Period end | Proceeds from Sale of Notes Receivable 3 month | Proceeds from Sale of Notes Receivable 6 month | Proceeds from Sale of Notes Receivable 9 month | Proceeds from Sale of Notes Receivable 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $18.80M derived: sum of 2 quarters · filed 2022-03-10 | $25.70M 10-K · filed 2022-03-10 | |
| 2021-09-30 | $18.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $25.70M 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | $6.90M 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |